Two Novel Variants in Genes of Arrhythmogenic Right Ventricular Cardiomyopathy - a Case Report.

Autor:	Gabartaitė D; Faculty of Medicine, Vilnius University, Vilnius, LithuaniaCentre of Cardiology and Angiology, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania., Jančauskaitė D; Faculty of Medicine, Vilnius University, Vilnius, LithuaniaCentre of Cardiology and Angiology, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania., Mikštienė V; Department of Human and Medical Genetics, Faculty of Medicine, Vilnius University, Vilnius, Lithuania., Preikšaitienė E; Department of Human and Medical Genetics, Faculty of Medicine, Vilnius University, Vilnius, Lithuania., Norvilas R; Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania., Valevičienė N; Centre of Radiology and Nuclear Medicine, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania., Marinskis G; Faculty of Medicine, Vilnius University, Vilnius, LithuaniaCentre of Cardiology and Angiology, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania., Aidietis A; Faculty of Medicine, Vilnius University, Vilnius, LithuaniaCentre of Cardiology and Angiology, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania., Barysienė J; Faculty of Medicine, Vilnius University, Vilnius, LithuaniaCentre of Cardiology and Angiology, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.
Jazyk:	angličtina
Zdroj:	Acta medica Lituanica [Acta Med Litu] 2021; Vol. 28 (1), pp. 127-135. Date of Electronic Publication: 2021 Jan 18.
DOI:	10.15388/Amed.2020.28.1.1
Abstrakt:	Summary Background: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a heritable cardiomyopathy, characterized by fibrofatty replacement of myocytes in the right ventricular, left ventricular or both ventricles. It is caused by pathogenic variants of genes encoding desmosomal ( JUP , DSP , PKP2 , DSG2 , DSC2) and non-desmosomal proteins, and is one of the most common causes of sudden cardiac death in young athletes. Therefore, early identification, correct prevention and treatment can prevent adverse outcomes. Case Report: Our case presents a 65-years-old man with recurrent ventricular tachycardia. The ischemic cause was the first to rule out. Echocardiography revealed right ventricular structural and functional abnormalities. After suspicion of ARVC, magnetic resonance imaging was performed showing reduced right ventricular ejection fraction with local aneurysms, structural changes ir the right and left myocardium. Subsequently performed genetic testing identified a novel ARVC likely pathogenic variant in DSC2 gene and variant of uncertain significance in RYR2 gene. Conclusions: Diagnostic evaluation of ARVC is challenging and requires multidisciplinary team collaboration. Further functional tests for elucidation of the clinical significance of the two novel variants of ARVC-associated genes could be suggested. Competing Interests: The authors declare no conflict of interest. (Copyright © 2021 Dovilė Gabartaitė, Dovilė Jančauskaitė, Violeta Mikštienė, Eglė Preikšaitienė, Rimvydas Norvilas, Nomeda Valevičienė, Germanas Marinskis, Audrius Aidietis, Jūratė Barysienė.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu